Patent · US Expired

Tumor antigens and CTL clones isolated by a novel procedure

US6710172B1 · kind B1 · utility

4Cited by

0References

1Claims

0Family size

Assignee

LUDWIG INSTITUTE FOR CANCER RESEARCH LTD · GB

Inventors

Pascal Chaux · Brussels, BE
Rosalie Luiten · Abcoude, NL
Nathalie Demotte · Brussels, BE
Marie-Therese Duffour · Paris, FR
Christophe Lurquin · Brussels, BE
Catie Traversari · Milano, IT
Vincent Stroobant · Brussels, BE
Guy R. Cornelis · Kraainem, BE
Thierry Boon-Falleur · Brussels, BE
Pierre van der Bruggen · Brussels, BE
Erwin Schultz · Erlangen, DE
Guy Warnier · Brussels, BE

Key dates

Filing date	Jul 30, 2001
Grant date	Mar 23, 2004
Priority date	—
Expiry date	Jul 30, 2021

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to nucleic acid molecules encoding antigenic peptides from MAGE molecules that bind to HLA. An example of the nucleic acid molecules of the present invention is a nucleic acid molecule coding for the peptide GVYDGREHTV (SEQ ID NO: 44), which peptide binds to HLA-A2. The nucleic acid molecules and the encoded antigenic peptides are useful for diagnosing and treating various pathological conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.